Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

ibrahim boran

Eagle Genomics Secures £590,000 To Expand Its Current Bioinformatics Offerings

3rd September 2013

Eagle Genomics (Eagle), an expert provider of bioinformatics software and services across a wide range of the life science and other sectors, [has][today] announced the first closing of £590,000.
Laboratory

CellCentric Gains £4.3m To Take Prostate Cancer Programme Through To Clinical Candidates

25th June 2013

New investment coupled with a major award from the UK’s innovation agency, the Technology Strategy Board, will provide funding for over two years to conduct lead optimisation and clinical candidate generation…
STFC #49 - Victoria Grigson - High Res

Mars To Volcanoes, Ash Clouds and Chimneystacks-UK Spin-Out Brings Space Technology to Earth

20th June 2013

KEIT Ltd is a brand new, forward thinking spin out company from the Science and Technology Facilities Council’s (STFC) RAL Space division.
Synthace research

£100,000 Investment For Microbiology Company

19th June 2013

A Company which offers bespoke microbiological testing has secured £100,000 investment.
Craig Parsons inspecting a sapphire pill in OXSENSIS' pilot line 1 laboratory at STFC's Rutherford Appleton Laboratory, 4th March 2014

Parker Aerospace and Oxsensis To Develop Highly Accurate Stable Fiber Optic Pressure Sensor

18th June 2013

Suitable for low temperatures and high vibrations, immune to EMI Reduces system weight and complexity.
Shared Experience Raising Venture Capital

Shared Experience From Raising Venture Capital for a Technology Business

4th June 2013

Tim Grasby recently joined Midven as an investment manager to develop its relationship with Harwell Capital,  targeting investment into UK based technology focused business.
Messages to the Chancellor

Messages to the Chancellor from VC Backed Companies

19th March 2013

Many of the companies that Midven works with are creating exciting products with international reach, but they are looking for more help in accessing and selling to these markets.

Clock

The 60 Second Marketer

18th February 2013

Midven Investment Manager Giovanni Finocchio has extensive sales and marketing experience within the SME environment, having held business development and marketing roles in five early stage businesses that were VC and business angel funded and will be sharing his views…
Nodes

Midven Annual Review 2013

18th February 2013

Midven Annual Review 2013
Funding for Growth

Funding For Growth – An Insight From The Coalface

17th January 2013

The path of raising finance for the entrepreneur is always a precarious balancing act.
Crescendo Biologics

Crescendo Biologics Announces Breakthrough Technology Progress

17th January 2013

Cambridge, UK. 16th January 2013 – Crescendo Biologics Limited (Crescendo) today announces the Crescendo Mouse, a breakthrough in antibody fragment technology.
Trophy

Business Awards – Are They of Any Value?

3rd December 2012

Hot on the heels of yet another Midven portfolio company securing an award the burning question has to be – is applying for, and winning, business awards of any value to your business?
national cancer institute

MoD Spin-Out Receives Funding For Technology That Promises Improved Earlier Detection And Treatment of Cancer

29th November 2012

ProKyma, a spin-out from the Defence Science and Technology Laboratory (Dstl), today announces a £482k award.
IGS roots in solid rock

Backing For Survey Firm With Roots In Solid Rock

29th October 2012

Nottingham-based BGS International, which spun out from the British Geological Survey in 2011, has received a further investment of £60,000 from the Nottingham office of Midven’s UK Innovation & Science Seed Fund.
alexander mils

Why Venture Capital is the Right Long Term Funding Partner for Growing Businesses

18th September 2012

Everywhere you look at the moment is risk, whether it be political, economic or financial, particular in relation to the ongoing travails within the EU.
Hand shake

Aitua Enters Into Option Agreement With Nicox To Acquire Altacor

16th March 2012

NicOx enters into option agreement to acquire Altacor as a first step towards building an international ophthalmology business.
Cobalt bottle scanner

Cobalt Light Systems Receives European Approval For It’s Bottle Scanner

7th January 2012

Cobalt Light Systems has received European approval for its revolutionary INSIGHT100 bottle scanner, which enables aircraft passengers to carry liquid items larger than 100ml once more.

Clinical Trials

New Antibiotic Compound Enters Phase 1 Clinical Trial

8th November 2011

Novacta Biosystems has commenced dosing of the first healthy volunteers in a phase 1 clinical trial of a new antibiotic to treat the hospital superbug Clostridium difficile.
Scientist at work

P2i Demonstrates Magical Protective Liquid Repellent Nano-Coating For Smartphones At IFA 2011

8th October 2011

Just one drop of liquid can destroy your phone or tablet! Acting like a barrier, Splash-Guard protects your XOOM 2 & XOOM 2 Media Edition from those unexpected spills and splashes.

Crescendo

Crescendo Biologics Appoints Matthew Roe as Chief Business Officer

8th June 2011

Cambridge, UK. 22 June 2011 – Crescendo Biologics Limited (Crescendo) today announces the appointment of Matthew Roe as Chief Business Officer.

Lab work

Mike Romanos Appointed CEO Of Crescendo Biologics

8th February 2011

UK. 12 October 2009 – Mike Romanos has been appointed Chief Scientific Officer of Crescendo Biologics (“Crescendo”) and joins the Board as a Director.
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.